MetaADEDB 2.0 @ LMMD
Ticagrelor
(OEKWJQXRCDYSHL-FNOIDJSQSA-N)
Structure
SMILES
CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO
Type(s)
Approved
ATC code(s)
B01AC24
Molecular Formula:
C23H28F2N6O4S
Molecular Weight:
522.568
Log P:
2.0867
Hydrogen Bond Acceptor:
11
Hydrogen Bond Donor:
4
TPSA:
163.74
CAS Number(s):
274693-27-5
Synonym(s)
1.
Ticagrelor
2.
3-(7-((2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-(1-3)-triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
3.
AZD 6140
4.
AZD-6140
5.
AZD6140
6.
Brilinta
7.
Brilique
External Link(s)
MeSHD000077486
PubChem Compound9871419
BindingDB50397205
ChEBI68558
CHEMBLCHEMBL398435
DrugBankDB08816
DrugCentral4184
IUPHAR/BPS Guide to PHARMACOLOGY1765
KEGGdr:D09017
Therapeutic Target DatabaseD0WF7L
D04PMQ
ZINC28957444
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 430
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
2Myocardial InfarctionFAERS: 422
Canada Vigilance: 2
Canada Vigilance
US FAERS
3MalaiseFAERS: 331US FAERS
4Drug dose omissionFAERS: 289US FAERS
5Chest PainFAERS: 235
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
6Feeling abnormalFAERS: 233SIDER
US FAERS
7AstheniaFAERS: 203
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
8Thrombosis in deviceFAERS: 190
Canada Vigilance: 6
Canada Vigilance
US FAERS
9Vascular stent thrombosisFAERS: 183
Canada Vigilance: 3
Canada Vigilance
US FAERS
10DizzinessFAERS: 176
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
11Intentional product misuseFAERS: 152
Canada Vigilance: 3
Canada Vigilance
US FAERS
12HeadacheFAERS: 116
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
13NauseaFAERS: 115
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
14EpistaxisFAERS: 102SIDER
US FAERS
15AnxietyFAERS: 101US FAERS
16Chest discomfortFAERS: 99US FAERS
17Memory impairmentFAERS: 97US FAERS
18Cerebrovascular accidentFAERS: 90US FAERS
19PainFAERS: 86
Canada Vigilance: 1
Canada Vigilance
US FAERS
20ThrombosisFAERS: 78
Canada Vigilance: 2
Canada Vigilance
US FAERS
21VomitingFAERS: 75SIDER
US FAERS
22Acute myocardial infarctionFAERS: 71
Canada Vigilance: 1
Canada Vigilance
US FAERS
23StressFAERS: 71US FAERS
24BradycardiaFAERS: 67
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
25SomnolenceFAERS: 67US FAERS
26Cardiac ArrestFAERS: 61
Canada Vigilance: 1
Canada Vigilance
US FAERS
27NasopharyngitisFAERS: 60
Canada Vigilance: 1
Canada Vigilance
US FAERS
28Product use issueFAERS: 52US FAERS
29Back PainFAERS: 51SIDER
US FAERS
30Angina PectorisFAERS: 50
Canada Vigilance: 2
Canada Vigilance
US FAERS
31Device occlusionFAERS: 48
Canada Vigilance: 1
Canada Vigilance
US FAERS
32Visual ImpairmentFAERS: 47US FAERS
33Weight decreasedFAERS: 47
Canada Vigilance: 1
Canada Vigilance
US FAERS
34Adverse eventFAERS: 46
Canada Vigilance: 3
Canada Vigilance
US FAERS
35PneumoniaFAERS: 46US FAERS
36Abdominal discomfortFAERS: 45US FAERS
37Diabetes MellitusFAERS: 45US FAERS
38InfarctionFAERS: 44US FAERS
39NervousnessFAERS: 42US FAERS
40HypotensionFAERS: 41SIDER
US FAERS
41SyncopeFAERS: 38
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
42ThrombocytopeniaFAERS: 38US FAERS
43PruritusFAERS: 37
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
44Acute Coronary SyndromeFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
45ArthralgiaFAERS: 36US FAERS
46PalpitationsFAERS: 35US FAERS
47Atrial FibrillationFAERS: 34SIDER
US FAERS
48Intentional drug misuseFAERS: 32US FAERS
49Therapy cessationFAERS: 30US FAERS
50AmnesiaFAERS: 29US FAERS
51Atrioventricular BlockFAERS: 29US FAERS
52Vascular occlusionFAERS: 29US FAERS
53Drug ineffectiveFAERS: 26US FAERS
54DysphoniaFAERS: 26US FAERS
55Vascular stent occlusionFAERS: 26US FAERS
56Mental impairmentFAERS: 25US FAERS
57DiscomfortFAERS: 24US FAERS
58Electrocardiogram abnormalFAERS: 24US FAERS
59Peripheral swellingFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
60UrticariaFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
61AgitationFAERS: 22US FAERS
62Coronary Artery DiseaseFAERS: 22
Canada Vigilance: 1
20620737CTD
Canada Vigilance
US FAERS
63DyspepsiaFAERS: 22
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
64TremorFAERS: 22US FAERS
65Oropharyngeal painFAERS: 20US FAERS
66Activities of daily living impairedFAERS: 19US FAERS
67HypersensitivityFAERS: 19
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
68Emotional disorderFAERS: 18US FAERS
69Frustration tolerance decreasedFAERS: 18US FAERS
70Product use in unapproved indicationFAERS: 18US FAERS
71Abdominal PainFAERS: 17SIDER
US FAERS
72BronchospasmFAERS: 17US FAERS
73AsphyxiaFAERS: 16US FAERS
74Circumstance or information capable of leading to medication errorFAERS: 16US FAERS
75ConstipationFAERS: 16SIDER
US FAERS
76Pericardial effusionFAERS: 16US FAERS
77VertigoFAERS: 16SIDER
US FAERS
78ArthritisFAERS: 15US FAERS
79AsthmaFAERS: 15US FAERS
80FlushingFAERS: 15US FAERS
81WheezingFAERS: 15US FAERS
82DehydrationFAERS: 14US FAERS
83Musculoskeletal PainFAERS: 14US FAERS
84MyalgiaFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
85Arterial restenosisFAERS: 13US FAERS
86Blood glucose increasedFAERS: 13US FAERS
87Depressed moodFAERS: 13US FAERS
88ErythemaFAERS: 13US FAERS
89FlatulenceFAERS: 13US FAERS
90GoutFAERS: 13
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
91InfluenzaFAERS: 13US FAERS
92Vascular stent stenosisFAERS: 13US FAERS
93AlopeciaFAERS: 12US FAERS
94CataractFAERS: 12US FAERS
95Feeling ColdFAERS: 12US FAERS
96AngerFAERS: 11US FAERS
97Blood urine presentFAERS: 11SIDER
US FAERS
98CholelithiasisFAERS: 11US FAERS
99Gastric ulcerFAERS: 11US FAERS
100LethargyFAERS: 11US FAERS
101SepsisFAERS: 11US FAERS
102Sinoatrial BlockFAERS: 11US FAERS
103SwellingFAERS: 11US FAERS
104Vascular stent restenosisFAERS: 11US FAERS
105AngioedemaFAERS: 10SIDER
US FAERS
106Increased tendency to bruiseFAERS: 10SIDER
US FAERS
107Intentional product use issueFAERS: 10US FAERS
108LacerationFAERS: 10US FAERS
109Limb discomfortFAERS: 10US FAERS
110Limb injuryFAERS: 10US FAERS
111Lip swellingFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
112TachycardiaFAERS: 10US FAERS
113Acute kidney injuryFAERS: 9US FAERS
114AneurysmFAERS: 9US FAERS
115BlindnessFAERS: 9US FAERS
116ChromaturiaFAERS: 9US FAERS
117Complication associated with deviceFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
118DisorientationFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
119Drug prescribing errorFAERS: 9US FAERS
120Dry skinFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
121InfectionFAERS: 9US FAERS
122Joint swellingFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
123MenorrhagiaFAERS: 9US FAERS
124NephrolithiasisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
125No adverse eventFAERS: 9US FAERS
126Post procedural complicationFAERS: 9US FAERS
127Product dose omissionFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
128ToothacheFAERS: 9US FAERS
129UlcerFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
130Urinary tract infectionFAERS: 9US FAERS
131AbasiaFAERS: 8US FAERS
132Brain DeathFAERS: 8US FAERS
133BronchitisFAERS: 8US FAERS
134ChillsFAERS: 8US FAERS
135Cold sweatFAERS: 8US FAERS
136DiverticulitisFAERS: 8US FAERS
137DysgeusiaFAERS: 8US FAERS
138Ejection Fraction DecreasedFAERS: 8US FAERS
139HyperventilationFAERS: 8US FAERS
140PericarditisFAERS: 8US FAERS
141Pulmonary EmbolismFAERS: 8US FAERS
142Respiratory distressFAERS: 8US FAERS
143SneezingFAERS: 8US FAERS
144Stent malfunctionFAERS: 8US FAERS
145Apparent deathFAERS: 7US FAERS
146CryingFAERS: 7US FAERS
147Musculoskeletal discomfortFAERS: 7US FAERS
148Musculoskeletal stiffnessFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
149Platelet function test abnormalFAERS: 7US FAERS
150Productive CoughFAERS: 7US FAERS
151ShockFAERS: 7SIDER
US FAERS
152SinusitisFAERS: 7US FAERS
153Sleep disorder due to general medical condition, insomnia typeFAERS: 7US FAERS
154Wrong technique in product usage processFAERS: 7US FAERS
155Blood cholesterol increasedFAERS: 6US FAERS
156Blood creatinine increasedFAERS: 6SIDER
US FAERS
157Cardiac TamponadeFAERS: 6SIDER
US FAERS
158Cerebral disorderFAERS: 6US FAERS
159ChokingFAERS: 6US FAERS
160CholecystitisFAERS: 6US FAERS
161DeafnessFAERS: 6US FAERS
162Deep Vein ThrombosisFAERS: 6US FAERS
163DementiaFAERS: 6US FAERS
164Ear discomfortFAERS: 6US FAERS
165Middle insomniaFAERS: 6US FAERS
166Myocardial necrosis marker increasedFAERS: 6US FAERS
167NoduleFAERS: 6US FAERS
168OverdoseFAERS: 6US FAERS
169Panic DisorderFAERS: 6US FAERS
170Respiratory FailureFAERS: 6US FAERS
171Respiratory arrestFAERS: 6US FAERS
172Therapeutic response unexpectedFAERS: 6US FAERS
173Throat irritationFAERS: 6US FAERS
174TinnitusFAERS: 6US FAERS
175Troponin increasedFAERS: 6US FAERS
176AphasiaFAERS: 5US FAERS
177Back disorderFAERS: 5US FAERS
178Cheyne-Stokes RespirationFAERS: 5US FAERS
179CystitisFAERS: 5US FAERS
180Drug dispensing errorFAERS: 5US FAERS
181Eye painFAERS: 5US FAERS
182General physical health deteriorationFAERS: 5US FAERS
183HerniaFAERS: 5US FAERS
184HypokinesiaFAERS: 5US FAERS
185HypophagiaFAERS: 5US FAERS
186Incorrect dose administeredFAERS: 5US FAERS
187Lower respiratory tract infectionFAERS: 5US FAERS
188Medication ErrorFAERS: 5US FAERS
189Medication residue presentFAERS: 5US FAERS
190Multiple allergiesFAERS: 5US FAERS
191Neck PainFAERS: 5US FAERS
192NeutropeniaFAERS: 5US FAERS
193Poor quality sleepFAERS: 5US FAERS
194Secretion dischargeFAERS: 5US FAERS
195TensionFAERS: 5US FAERS
196AgeusiaFAERS: 4US FAERS
197Aortic AneurysmFAERS: 4US FAERS
198AphoniaFAERS: 4US FAERS
199ArthropathyFAERS: 4US FAERS
200Atrial FlutterFAERS: 4US FAERS
201Carotid artery occlusionFAERS: 4US FAERS
202ColitisFAERS: 4US FAERS
203Duodenal UlcerFAERS: 4US FAERS
204DysgraphiaFAERS: 4US FAERS
205EructationFAERS: 4US FAERS
206ImpatienceFAERS: 4US FAERS
207Inappropriate schedule of drug administrationFAERS: 4US FAERS
208IncoherentFAERS: 4US FAERS
209Insurance issueFAERS: 4US FAERS
210Mental status changesFAERS: 4US FAERS
211PancreatitisFAERS: 4US FAERS
212PancytopeniaFAERS: 4US FAERS
213Procedural complicationFAERS: 4US FAERS
214Product physical issueFAERS: 4US FAERS
215Product supply issueFAERS: 4US FAERS
216Respiratory DepressionFAERS: 4US FAERS
217Respiratory tract congestionFAERS: 4US FAERS
218RestlessnessFAERS: 4US FAERS
219SciaticaFAERS: 4US FAERS
220Skin irritationFAERS: 4US FAERS
221Sudden deathFAERS: 4US FAERS
222Thrombocytopenic purpuraFAERS: 4US FAERS
223Venous occlusionFAERS: 4US FAERS
224Ventricular FibrillationFAERS: 4US FAERS
225Altered state of consciousnessFAERS: 3US FAERS
226Anaphylactic shockFAERS: 3US FAERS
227AppendicitisFAERS: 3US FAERS
228Arterial thrombosisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
229AtelectasisFAERS: 3US FAERS
230Blood blisterFAERS: 3US FAERS
231Blood cholesterol abnormalFAERS: 3US FAERS
232Blood glucose decreasedFAERS: 3US FAERS
233Blood pressure fluctuationFAERS: 3US FAERS
234Burning sensationFAERS: 3US FAERS
235CellulitisFAERS: 3US FAERS
236DeliriumFAERS: 3US FAERS
237Depressed Level of ConsciousnessFAERS: 3US FAERS
238DiplopiaFAERS: 3US FAERS
239Drug resistanceFAERS: 3US FAERS
240DysenteryFAERS: 3US FAERS
241EcchymosisFAERS: 3SIDER
US FAERS
242Emotional distressFAERS: 3US FAERS
243Fluid overloadFAERS: 3US FAERS
244Gastrointestinal PainFAERS: 3SIDER
US FAERS
245HemiparesisFAERS: 3US FAERS
246HypersomniaFAERS: 3US FAERS
247Hypertensive crisisFAERS: 3US FAERS
248IleusFAERS: 3US FAERS
249In-stent coronary artery restenosisFAERS: 3US FAERS
250Inability to afford medicationFAERS: 3US FAERS
251InflammationFAERS: 3US FAERS
252Intestinal PerforationFAERS: 3US FAERS
253LaryngitisFAERS: 3US FAERS
254Musculoskeletal chest painFAERS: 3US FAERS
255Nasal PolypsFAERS: 3US FAERS
256Peripheral artery thrombosisFAERS: 3US FAERS
257PetechiaeFAERS: 3SIDER
US FAERS
258PhotophobiaFAERS: 3US FAERS
259PresyncopeFAERS: 3SIDER
US FAERS
260Product quality issueFAERS: 3US FAERS
261Product solubility abnormalFAERS: 3US FAERS
262PurpuraFAERS: 3US FAERS
263Rash erythematousFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
264ReocclusionFAERS: 3US FAERS
265Rheumatoid ArthritisFAERS: 3US FAERS
266SluggishnessFAERS: 3US FAERS
267ThrombocytosisFAERS: 3US FAERS
268Unresponsive to stimuliFAERS: 3US FAERS
269Urinary RetentionFAERS: 3US FAERS
270Ventricular arrhythmiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
271Wrong drug administeredFAERS: 3US FAERS
272nervous system disorderFAERS: 3SIDER
US FAERS
273Accidental overdoseFAERS: 2US FAERS
274Alanine Aminotransferase IncreasedFAERS: 2US FAERS
275Animal scratchFAERS: 2US FAERS
276Basal cell carcinomaFAERS: 2US FAERS
277Blood creatine increasedFAERS: 2US FAERS
278Blood glucose fluctuationFAERS: 2US FAERS
279Blood magnesium decreasedFAERS: 2US FAERS
280Blood potassium decreasedFAERS: 2US FAERS
281Blood triglycerides increasedFAERS: 2US FAERS
282Bone painFAERS: 2US FAERS
283BradyphreniaFAERS: 2US FAERS
284Breast tendernessFAERS: 2US FAERS
285Cardiac FlutterFAERS: 2US FAERS
286Cardiac ventricular thrombosisFAERS: 2US FAERS
287Cerebral InfarctionFAERS: 2US FAERS
288Choking sensationFAERS: 2US FAERS
289Completed SuicideFAERS: 2US FAERS
290Coronary artery insufficiencyFAERS: 2US FAERS
291Coronary artery reocclusionFAERS: 2US FAERS
292Dental cariesFAERS: 2US FAERS
293Disease ProgressionFAERS: 2US FAERS
294Disease complicationFAERS: 2US FAERS
295Disseminated Intravascular CoagulationFAERS: 2US FAERS
296DrowningFAERS: 2US FAERS
297Embolic strokeFAERS: 2US FAERS
298EmbolismFAERS: 2US FAERS
299EosinophiliaFAERS: 2US FAERS
300Facial PainFAERS: 2US FAERS
301Failure to ThriveFAERS: 2US FAERS
302Full blood count decreasedFAERS: 2US FAERS
303Gait inabilityFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
304GastritisFAERS: 2SIDER
US FAERS
305HepatitisFAERS: 2US FAERS
306HypoxiaFAERS: 2US FAERS
307Impaired driving abilityFAERS: 2US FAERS
308Impaired gastric emptyingFAERS: 2US FAERS
309Impaired work abilityFAERS: 2US FAERS
310IncontinenceFAERS: 2US FAERS
311Intracranial AneurysmFAERS: 2US FAERS
312Lactose IntoleranceFAERS: 2US FAERS
313LazinessFAERS: 2US FAERS
314LeukopeniaFAERS: 2US FAERS
315LymphadenopathyFAERS: 2US FAERS
316MYELODYSPLASTIC SYNDROMEFAERS: 2US FAERS
317Meniscus injuryFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
318Mental FatigueFAERS: 2US FAERS
319MetastasisFAERS: 2US FAERS
320Multiple SclerosisFAERS: 2US FAERS
321Nephrotic SyndromeFAERS: 2US FAERS
322ObesityFAERS: 2US FAERS
323ParanoiaFAERS: 2US FAERS
324ParaplegiaFAERS: 2US FAERS
325Performance status decreasedFAERS: 2US FAERS
326Peripheral artery occlusionFAERS: 2US FAERS
327Personality ChangeFAERS: 2US FAERS
328PhlebitisFAERS: 2US FAERS
329Platelet aggregation abnormalFAERS: 2US FAERS
330Platelet aggregation decreasedFAERS: 2US FAERS
331PneumonitisFAERS: 2US FAERS
332PneumothoraxFAERS: 2US FAERS
333Post-Traumatic Stress DisorderFAERS: 2US FAERS
334Product dispensing errorFAERS: 2US FAERS
335Product name confusionFAERS: 2US FAERS
336Product size issueFAERS: 2US FAERS
337Product used for unknown indicationFAERS: 2US FAERS
338PsoriasisFAERS: 2US FAERS
339Psychiatric symptomFAERS: 2US FAERS
340RalesFAERS: 2US FAERS
341Renal ColicFAERS: 2US FAERS
342Renal cystFAERS: 2US FAERS
343Renal painFAERS: 2US FAERS
344ScabFAERS: 2US FAERS
345Sinus headacheFAERS: 2US FAERS
346StenosisFAERS: 2US FAERS
347StomatitisFAERS: 2US FAERS
348Suicide attemptFAERS: 2US FAERS
349TachyarrhythmiaFAERS: 2US FAERS
350Thrombotic strokeFAERS: 2US FAERS
351Tooth InfectionFAERS: 2US FAERS
352Tooth LossFAERS: 2US FAERS
353Unevaluable eventFAERS: 2US FAERS
354Upper-airway cough syndromeFAERS: 2US FAERS
355Vascular dissectionFAERS: 2US FAERS
356Vascular ruptureFAERS: 2US FAERS
357VasculitisFAERS: 2US FAERS
358Venous ThrombosisFAERS: 2US FAERS
359jaundiceFAERS: 2US FAERS
360Abdominal AbscessFAERS: 1US FAERS
361Abdominal InfectionFAERS: 1US FAERS
362AcneFAERS: 1US FAERS
363Acute Lung InjuryFAERS: 1US FAERS
364Acute respiratory failureFAERS: 1US FAERS
365Alcohol abuseFAERS: 1US FAERS
366Allergic sinusitisFAERS: 1US FAERS
367Allergy to chemicalsFAERS: 1US FAERS
368AllodyniaFAERS: 1US FAERS
369Ammonia abnormalFAERS: 1US FAERS
370Anal FissureFAERS: 1US FAERS
371AngioplastyFAERS: 1US FAERS
372Ankle FractureFAERS: 1US FAERS
373Aortic Valve StenosisFAERS: 1US FAERS
374Aortic occlusionFAERS: 1US FAERS
375Application site discomfortFAERS: 1US FAERS
376Application site swellingFAERS: 1US FAERS
377ArteriosclerosisFAERS: 1US FAERS
378AscitesFAERS: 1US FAERS
379Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
380AsthenopiaFAERS: 1US FAERS
381AtaxiaFAERS: 1US FAERS
382Atypical pneumoniaFAERS: 1US FAERS
383Benign neoplasm of thyroid glandFAERS: 1US FAERS
384Bipolar II disorderFAERS: 1US FAERS
385Bladder NeoplasmFAERS: 1US FAERS
386Blood alkaline phosphatase increasedFAERS: 1US FAERS
387Blood count abnormalFAERS: 1US FAERS
388Blood creatine phosphokinase increasedFAERS: 1US FAERS
389Blood creatinine abnormalFAERS: 1US FAERS
390Blood iron decreasedFAERS: 1US FAERS
391Blood potassium increasedFAERS: 1US FAERS
392Blood pressure inadequately controlledFAERS: 1US FAERS
393Blood urea increasedFAERS: 1US FAERS
394Bowel movement irregularityFAERS: 1US FAERS
395Brain ContusionFAERS: 1US FAERS
396Brain HypoxiaFAERS: 1US FAERS
397Brain stem syndromeFAERS: 1US FAERS
398Breakthrough PainFAERS: 1US FAERS
399Breath HoldingFAERS: 1US FAERS
400Breathing-related sleep disorderFAERS: 1US FAERS
401Bronchial irritationFAERS: 1US FAERS
402Bronchial secretion retentionFAERS: 1US FAERS
403CD4 Lymphocytes DecreasedFAERS: 1US FAERS
404CREST SyndromeFAERS: 1US FAERS
405Cardiac discomfortFAERS: 1US FAERS
406Cardiac enzymes increasedFAERS: 1US FAERS
407Cardiac function disturbance postoperativeFAERS: 1US FAERS
408Cardiac perforationFAERS: 1US FAERS
409Cardiac stress test abnormalFAERS: 1US FAERS
410Cardiac valve ruptureFAERS: 1US FAERS
411Cardiac ventricular disorderFAERS: 1US FAERS
412Cardio-respiratory distressFAERS: 1US FAERS
413CardiomegalyFAERS: 1US FAERS
414CarditisFAERS: 1US FAERS
415Carotid artery restenosisFAERS: 1US FAERS
416Central nervous system lesionFAERS: 1US FAERS
417Cerebral ThrombosisFAERS: 1US FAERS
418Cerebral vascular occlusionFAERS: 1US FAERS
419Cerebrovascular stenosisFAERS: 1US FAERS
420Chemical peritonitisFAERS: 1US FAERS
421CholangiocarcinomaFAERS: 1US FAERS
422CholestasisFAERS: 1US FAERS
423ChondrosisFAERS: 1US FAERS
424Clostridium difficile infectionFAERS: 1US FAERS
425Coagulation time abnormalFAERS: 1US FAERS
426Coagulation time shortenedFAERS: 1US FAERS
427Contrast media reactionFAERS: 1US FAERS
428Counterfeit drug administeredFAERS: 1US FAERS
429Creatinine renal clearance decreasedFAERS: 1US FAERS
430Creatinine renal clearance increasedFAERS: 1US FAERS
431CyanosisFAERS: 1US FAERS
432CystFAERS: 1US FAERS
433Dengue FeverFAERS: 1US FAERS
434DermatitisFAERS: 1SIDER
US FAERS
435Device breakageFAERS: 1US FAERS
436Device defectiveFAERS: 1US FAERS
437Device malfunctionFAERS: 1US FAERS
438Diabetes mellitus inadequate controlFAERS: 1US FAERS
439Diabetic arteritisFAERS: 1US FAERS
440Dialysis related complicationFAERS: 1US FAERS
441Disease recurrenceFAERS: 1US FAERS
442Dissociative disorderFAERS: 1US FAERS
443DiverticulumFAERS: 1US FAERS
444Drug abuseFAERS: 1US FAERS
445Drug administered to patient of inappropriate ageFAERS: 1US FAERS
446Drug administration errorFAERS: 1US FAERS
447Drug effect incompleteFAERS: 1US FAERS
448DysarthriaFAERS: 1US FAERS
449DyslexiaFAERS: 1US FAERS
450DysuriaFAERS: 1US FAERS
451Ear, nose and throat examination abnormalFAERS: 1US FAERS
452Economic problemFAERS: 1US FAERS
453Ejection fraction abnormalFAERS: 1US FAERS
454EndocarditisFAERS: 1US FAERS
455Enterococcal infectionFAERS: 1US FAERS
456Enzyme level increasedFAERS: 1US FAERS
457Epigastric discomfortFAERS: 1US FAERS
458EpilepsyFAERS: 1US FAERS
459Erectile dysfunctionFAERS: 1US FAERS
460Escherichia test positiveFAERS: 1US FAERS
461Essential HypertensionFAERS: 1US FAERS
462Euphoric moodFAERS: 1US FAERS
463Exfoliative rashFAERS: 1US FAERS
464Expired drug administeredFAERS: 1US FAERS
465Extra dose administeredFAERS: 1US FAERS
466Eye InfectionFAERS: 1US FAERS
467Facial NeuralgiaFAERS: 1US FAERS
468Feeling jitteryFAERS: 1US FAERS
469Feeling of body temperature changeFAERS: 1US FAERS
470Food PoisoningFAERS: 1US FAERS
471FrustrationFAERS: 1US FAERS
472Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
473Gastrointestinal bacterial infectionFAERS: 1US FAERS
474Gastrointestinal motility disorderFAERS: 1US FAERS
475Gastrointestinal perforationFAERS: 1US FAERS
476Gastrointestinal ulcerFAERS: 1US FAERS
477GingivitisFAERS: 1US FAERS
478GlaucomaFAERS: 1US FAERS
479Gliomatosis cerebriFAERS: 1US FAERS
480GliomaFAERS: 1US FAERS
481Graft overgrowthFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
482Graft thrombosisFAERS: 1US FAERS
483HaematinuriaFAERS: 1US FAERS
484HemiplegiaFAERS: 1US FAERS
485Hepatitis CFAERS: 1US FAERS
486HydrocephalusFAERS: 1US FAERS
487HydronephrosisFAERS: 1US FAERS
488HyperchlorhydriaFAERS: 1US FAERS
489HyperkeratosisFAERS: 1US FAERS
490HyperthyroidismFAERS: 1US FAERS
491HypertrichosisFAERS: 1US FAERS
492HypogeusiaFAERS: 1US FAERS
493HypothyroidismFAERS: 1US FAERS
494Immune thrombocytopenic purpuraFAERS: 1US FAERS
495Impaired quality of lifeFAERS: 1US FAERS
496Implant site painFAERS: 1US FAERS
497Implantable defibrillator insertionFAERS: 1US FAERS
498Incision site painFAERS: 1US FAERS
499Incision site swellingFAERS: 1US FAERS
500Incorrect drug administration durationFAERS: 1US FAERS
501Incorrect product administration durationFAERS: 1US FAERS
502Infection in an immunocompromised hostFAERS: 1US FAERS
503Intellectual DisabilityFAERS: 1US FAERS
504Intentional dose omissionFAERS: 1US FAERS
505Intentional self-injuryFAERS: 1US FAERS
506Intercepted drug dispensing errorFAERS: 1US FAERS
507Intercepted drug prescribing errorFAERS: 1US FAERS
508Intercepted product dispensing errorFAERS: 1US FAERS
509Intervertebral Disc DegenerationFAERS: 1US FAERS
510Intestinal ObstructionFAERS: 1US FAERS
511Intracranial massFAERS: 1US FAERS
512Irregular breathingFAERS: 1US FAERS
513Irritable Bowel SyndromeFAERS: 1US FAERS
514Itching scarFAERS: 1US FAERS
515Joint Range of Motion DecreasedFAERS: 1US FAERS
516Joint injuryFAERS: 1US FAERS
517Joint stiffnessFAERS: 1US FAERS
518Laryngeal discomfortFAERS: 1US FAERS
519Left Ventricular HypertrophyFAERS: 1US FAERS
520LeukocytosisFAERS: 1US FAERS
521Lip exfoliationFAERS: 1US FAERS
522Lipase increasedFAERS: 1US FAERS
523Long QT SyndromeFAERS: 1US FAERS
524Low density lipoprotein increasedFAERS: 1US FAERS
525LymphadenitisFAERS: 1US FAERS
526LymphomaFAERS: 1US FAERS
527Macular degenerationFAERS: 1US FAERS
528Malignant ascitesFAERS: 1US FAERS
529MalnutritionFAERS: 1SIDER
US FAERS
530MastitisFAERS: 1US FAERS
531Medical device site calcificationFAERS: 1US FAERS
532MeningitisFAERS: 1US FAERS
533Metabolic acidosisFAERS: 1US FAERS
534Micturition frequency decreasedFAERS: 1US FAERS
535Migraine with AuraFAERS: 1US FAERS
536MiliariaFAERS: 1US FAERS
537MonoparesisFAERS: 1US FAERS
538MonoplegiaFAERS: 1US FAERS
539Motion SicknessFAERS: 1US FAERS
540Muscle strainFAERS: 1US FAERS
541Muscle tightnessFAERS: 1US FAERS
542Myocardial fibrosisFAERS: 1US FAERS
543NeuralgiaFAERS: 1US FAERS
544New daily persistent headacheFAERS: 1US FAERS
545NocturiaFAERS: 1US FAERS
546Non-cardiac chest painFAERS: 1SIDER
US FAERS
547Noninfective encephalitisFAERS: 1US FAERS
548Nonspecific reactionFAERS: 1US FAERS
549ObstructionFAERS: 1US FAERS
550Ocular discomfortFAERS: 1US FAERS
551Ocular icterusFAERS: 1US FAERS
552Oral candidiasisFAERS: 1US FAERS
553Oral painFAERS: 1US FAERS
554OsteomyelitisFAERS: 1US FAERS
555PallorFAERS: 1US FAERS
556Papillary muscle disorderFAERS: 1US FAERS
557Paroxysmal atrioventricular blockFAERS: 1US FAERS
558Pelvic PainFAERS: 1US FAERS
559Peptic UlcerFAERS: 1US FAERS
560Percutaneous Coronary InterventionFAERS: 1US FAERS
561Periorbital contusionFAERS: 1US FAERS
562Peripheral arterial occlusive diseaseFAERS: 1US FAERS
563Peripheral nerve lesionFAERS: 1US FAERS
564Peripheral venous diseaseFAERS: 1US FAERS
565PeritonitisFAERS: 1US FAERS
566Platelet aggregation inhibitionFAERS: 1US FAERS
567Platelet count abnormalFAERS: 1US FAERS
568PoisoningFAERS: 1US FAERS
569PolyneuropathyFAERS: 1US FAERS
570Post procedural pneumoniaFAERS: 1US FAERS
571Post procedural swellingFAERS: 1US FAERS
572Postoperative renal failureFAERS: 1US FAERS
573Pre-existing condition improvedFAERS: 1US FAERS
574Product barcode issueFAERS: 1US FAERS
575Product container issueFAERS: 1US FAERS
576Product contaminationFAERS: 1US FAERS
577Product counterfeitFAERS: 1US FAERS
578Product dosage form issueFAERS: 1US FAERS
579Product packaging issueFAERS: 1US FAERS
580Product prescribing errorFAERS: 1US FAERS
581Product prescribing issueFAERS: 1US FAERS
582Product residue presentFAERS: 1US FAERS
583Product use complaintFAERS: 1US FAERS
584ProteinuriaFAERS: 1US FAERS
585Prothrombin level abnormalFAERS: 1US FAERS
586Psoas AbscessFAERS: 1US FAERS
587Pulmonary FibrosisFAERS: 1US FAERS
588Pulmonary hilar enlargementFAERS: 1US FAERS
589Pulmonary thrombosisFAERS: 1US FAERS
590Pulmonary vascular disorderFAERS: 1US FAERS
591Puncture site dischargeFAERS: 1US FAERS
592PyelonephritisFAERS: 1US FAERS
593Rebound effectFAERS: 1US FAERS
594Rectal polypFAERS: 1US FAERS
595RegurgitationFAERS: 1US FAERS
596Renal massFAERS: 1US FAERS
597Renal tubular necrosisFAERS: 1US FAERS
598Reperfusion arrhythmiaFAERS: 1US FAERS
599Respiratory rateFAERS: 1US FAERS
600Restless Legs SyndromeFAERS: 1US FAERS
601RetchingFAERS: 1US FAERS
602Retinal DetachmentFAERS: 1US FAERS
603Retroperitoneal abscessFAERS: 1US FAERS
604RhabdomyolysisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
605Right Ventricular DysfunctionFAERS: 1US FAERS
606Rotator cuff syndromeFAERS: 1US FAERS
607Schizotypal Personality DisorderFAERS: 1US FAERS
608Seizure like phenomenaFAERS: 1US FAERS
609Sense of oppressionFAERS: 1US FAERS
610Septic ShockFAERS: 1US FAERS
611Septic embolusFAERS: 1US FAERS
612Sexual DysfunctionFAERS: 1US FAERS
613Sinus bradycardiaFAERS: 1US FAERS
614Skin IndurationFAERS: 1US FAERS
615Skin UlcerFAERS: 1US FAERS
616Skin lesionFAERS: 1US FAERS
617Skin reactionFAERS: 1US FAERS
618Sleep disorder due to a general medical conditionFAERS: 1US FAERS
619Spinal column stenosisFAERS: 1US FAERS
620StaringFAERS: 1US FAERS
621StuporFAERS: 1US FAERS
622Sudden Cardiac DeathFAERS: 1US FAERS
623Suicide threatFAERS: 1US FAERS
624Supraventricular tachycardiaFAERS: 1US FAERS
625Symptom recurrenceFAERS: 1US FAERS
626Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
627TachyphreniaFAERS: 1US FAERS
628Temperature intoleranceFAERS: 1US FAERS
629Therapeutic product ineffectiveFAERS: 1US FAERS
630Thermal burnFAERS: 1US FAERS
631ThirstFAERS: 1US FAERS
632Throat cancerFAERS: 1US FAERS
633Tongue bitingFAERS: 1US FAERS
634Tongue eruptionFAERS: 1US FAERS
635Tongue erythemaFAERS: 1US FAERS
636Toxic Epidermal NecrolysisFAERS: 1US FAERS
637TrichorrhexisFAERS: 1US FAERS
638TuberculosisFAERS: 1US FAERS
639Tumour haemorrhageFAERS: 1US FAERS
640UnderweightFAERS: 1US FAERS
641Urinary IncontinenceFAERS: 1US FAERS
642Urinary tract discomfortFAERS: 1US FAERS
643VIIth nerve paralysisFAERS: 1US FAERS
644Vascular access site painFAERS: 1US FAERS
645Vascular compressionFAERS: 1US FAERS
646Vascular stenosisFAERS: 1US FAERS
647Ventricular DysfunctionFAERS: 1US FAERS
648Ventricular dyssynchronyFAERS: 1US FAERS
649Ventricular hypertrophyFAERS: 1US FAERS
650Vitreous floatersFAERS: 1US FAERS
651Wheelchair userFAERS: 1US FAERS
652Wound ComplicationFAERS: 1US FAERS
653Wrong scheduleFAERS: 1US FAERS
654YawningFAERS: 1US FAERS
655effusionFAERS: 1US FAERS
656furuncleFAERS: 1US FAERS
657prostatitisFAERS: 1US FAERS
658Benign Prostatic HyperplasiaCanada Vigilance: 3Canada Vigilance
659Dyspnea20620737
28041785
CTD
660Ear and labyrinth disordersSIDER
661Major bleedSIDER
662MetrorrhagiaSIDER
663Minor bleedSIDER
664OliguriaSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.